✦ LIBER ✦

P53 and bcl-2 assessment in serous ovarian carcinoma

✍ Scribed by J.E. PALMER; L.J. SANT CASSIA; C.J. IRWIN; A.G. MORRIS; T.P. ROLLASON

Book ID: 109086201
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 98 KB
Volume: 18
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2007.01000.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p53 and BCL-2 as Prognostic Markers in E

p53 and BCL-2 as Prognostic Markers in Endometrial Carcinoma

✍ Márcia L. M. Appel; Maria I. Edelweiss; James Fleck; Luis F. Rivero; Waldemar A. 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 170 KB

Expression of pro-apoptotic (p53, p21, b

Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours

✍ Raffaèle Fauvet; Charlotte Dufournet; Christophe Poncelet; Catherine Uzan; Daniè 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

WT-1 assists in distinguishing ovarian f

WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma

✍ M Al-Hussaini; A Stockman; H Foster; W G McCluggage 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

Combination of serum hCGβ and p53 tissue

Combination of serum hCGβ and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma

✍ Juhani Vartiainen; Heini Lassus; Pentti Lehtovirta; Patrik Finne; Henrik Alfthan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 89 KB

## Abstract Serous ovarian carcinoma comprises a clinically heterogenous group of tumors, and molecular markers stratifying patients into clinically meaningful subgroups are needed. Numerous markers have been evaluated, but none of them has yet been routinely incorporated into clinical practice. Pr

WT1, p53 and hormone receptor expression

WT1, p53 and hormone receptor expression in uterine serous carcinoma

✍ Lynn Hirschowitz; Raji Ganesan; W Glenn McCluggage 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB

Chemosensitivity and p53-dependent apopt

Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma

✍ Shinya Sato; Junzo Kigawa; Yukihisa Minagawa; Makoto Okada; Muneaki Shimada; Mas 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

## BACKGROUND. Although p53 gene mutation frequently is observed in ovarian carcinoma, the function of the p53 gene in chemosensitivity has not been defined conclusively. The objective of the current study was to elucidate the relation between chemotherapy-induced apoptosis through the p53 pathway